Joseph Edelman - Net Worth and Insider Trading
Joseph Edelman Net Worth
The estimated net worth of Joseph Edelman is at least $7 Million dollars as of 2024-05-13. Joseph Edelman is the Director, 10% Owner of Athira Pharma Inc and owns about 3,114,805 shares of Athira Pharma Inc (ATHA) stock worth over $7 Million. Details can be seen in Joseph Edelman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joseph Edelman has not made any transactions after 2020-09-22 and currently still holds the listed stock(s).
Transaction Summary of Joseph Edelman
Joseph Edelman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph Edelman owns 48 companies in total, including ARYA Sciences Acquisition Corp II (ARYBU) , Athira Pharma Inc (ATHA) , and Quotient Ltd (QTNTQ) among others .
Click here to see the complete history of Joseph Edelman’s form 4 insider trades.
Insider Ownership Summary of Joseph Edelman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARYBU | ARYA Sciences Acquisition Corp II | 2020-10-20 | director |
| ATHA | Athira Pharma Inc | 2021-01-25 | director & 10 percent owner |
| QTNTQ | Quotient Ltd | 2018-12-07 | 10 percent owner |
 | | 2019-05-03 | 10 percent owner |
| | 2020-02-03 | 10 percent owner |
| | 2020-08-06 | director |
| | 2020-07-09 | 10 percent owner |
| | 2020-03-09 | 10 percent owner |
| | 2018-01-25 | 10 percent owner |
| | 2020-03-09 | director & 10 percent owner |
| | 2019-06-19 | 10 percent owner |
| | 2020-04-30 | director & 10 percent owner |
| | 2018-12-13 | 10 percent owner |
| | 2020-04-17 | 10 percent owner |
| | 2019-05-21 | 10 percent owner |
| | 2019-03-04 | 10 percent owner |
| | 2019-11-18 | 10 percent owner |
| | 2019-11-12 | 10 percent owner |
| | 2019-07-29 | 10 percent owner |
| | 2018-02-14 | 10 percent owner |
| | 2018-09-12 | 10 percent owner |
| | 2019-01-07 | 10 percent owner |
| | 2018-10-11 | 10 percent owner |
| | 2018-10-05 | director |
| | 2018-08-10 | 10 percent owner |
| | 2018-06-14 | 10 percent owner |
| | 2017-12-14 | 10 percent owner |
| | 2017-09-21 | 10 percent owner |
| | 2017-06-19 | 10 percent owner |
| | 2013-06-15 | 10 percent owner |
| | 2008-01-03 | 10 percent owner |
| | 2003-08-04 | 10 percent owner |
| | 2004-02-06 | 10 percent owner |
| | 2003-05-29 | 10 percent owner |
| | 2020-12-21 | 10 percent owner |
| | 2021-01-28 | director & 10 percent owner |
| | 2021-10-07 | 10 percent owner |
| | 2021-03-11 | 10 percent owner |
| | 2021-04-22 | 10 percent owner |
| | 2021-08-27 | director |
| | 2020-10-20 | director |
| | 2021-12-08 | 10 percent owner |
| | 2021-10-29 | 10 percent owner |
| | 2021-02-25 | director |
| | 2021-07-12 | director |
| | 2022-11-17 | 10 percent owner |
| | 2023-04-04 | 10 percent owner |
| | 2023-05-19 | 10 percent owner |
Joseph Edelman Latest Holdings Summary
Joseph Edelman currently owns a total of 1 stock. Joseph Edelman owns 3,114,805 shares of Athira Pharma Inc (ATHA) as of September 22, 2020, with a value of $7 Million.
Latest Holdings of Joseph Edelman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATHA | Athira Pharma Inc | 2020-09-22 | 3,114,805 | 2.12 | 6,603,387 |
Holding Weightings of Joseph Edelman
Joseph Edelman Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph Edelman has made a total of 1 transactions in Athira Pharma Inc (ATHA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Athira Pharma Inc is the acquisition of 1,058,824 shares on September 22, 2020, which cost Joseph Edelman around $18 Million.
Insider Trading History of Joseph Edelman
- 1
Joseph Edelman Trading Performance
GuruFocus tracks the stock performance after each of Joseph Edelman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph Edelman is 103.06%. GuruFocus also compares Joseph Edelman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph Edelman within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joseph Edelman's insider trading performs compared to the benchmark.
Performance of Joseph Edelman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.72 | | | | | |
| Relative Return to S&P 500(%) | 16.56 | | | | | |
Joseph Edelman Ownership Network
Joseph Edelman Owned Company Details
What does ARYA Sciences Acquisition Corp II do?
Who are the key executives at ARYA Sciences Acquisition Corp II?
Joseph Edelman is the director of ARYA Sciences Acquisition Corp II. Other key executives at ARYA Sciences Acquisition Corp II include director & Chief Executive Officer Adam Leo Stone , director & Chief Financial Officer Michael Seth Altman , and 10 percent owner Arya Sciences Holdings Ii .
ARYA Sciences Acquisition Corp II (ARYBU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of ARYA Sciences Acquisition Corp II (ARYBU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYA Sciences Acquisition Corp II (ARYBU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ARYA Sciences Acquisition Corp II (ARYBU)'s detailed insider trading history can be found in Insider Trading Tracker table.
ARYA Sciences Acquisition Corp II Insider Transactions
- Download to Excel(.xls)
What does Athira Pharma Inc do?
Who are the key executives at Athira Pharma Inc?
Joseph Edelman is the director & 10 percent owner of Athira Pharma Inc. Other key executives at Athira Pharma Inc include See Below Andrew Gengos , Chief Operating Officer Mark James Litton , and Vice President of Discovery Kevin Church .
Athira Pharma Inc (ATHA) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in Athira Pharma Inc (ATHA). Other recent insider transactions involving Athira Pharma Inc (ATHA) include a net purchase of 77,596 shares made by Andrew Gengos , a net sale of 9,640 shares made by Mark James Litton , and a net sale of 4,824 shares made by Mark Worthington .
In summary, during the past 3 months, insiders sold 0 shares of Athira Pharma Inc (ATHA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 26,528 shares of Athira Pharma Inc (ATHA) were sold and 800,698 shares were bought by its insiders, resulting in a net purchase of 774,170 shares.
Athira Pharma Inc (ATHA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Athira Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does Quotient Ltd do?
Who are the key executives at Quotient Ltd?
Joseph Edelman is the 10 percent owner of Quotient Ltd. Other key executives at Quotient Ltd include 10 percent owner Highbridge Capital Management Llc , 10 percent owner Quotient Holdings Finance Co Ltd , and 10 percent owner Quotient Holdings Newco, Lp .
Quotient Ltd (QTNTQ) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in Quotient Ltd (QTNTQ). Other recent insider transactions involving Quotient Ltd (QTNTQ) include a net sale of 25,000 shares made by Prondzynski Heino Von , and a net sale of 1,014 shares made by Isabelle Buckle .
In summary, during the past 3 months, insiders sold 0 shares of Quotient Ltd (QTNTQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 26,014 shares of Quotient Ltd (QTNTQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 26,014 shares.
Quotient Ltd (QTNTQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Quotient Ltd Insider Transactions
- Download to Excel(.xls)
What does Athenex Inc do?
Who are the key executives at Athenex Inc?
Joseph Edelman is the 10 percent owner of Athenex Inc. Other key executives at Athenex Inc include director & CEO and Chairman of the Board Lau Johnson Yiu Nam , Chief Financial Officer Joe Annoni , and See Remarks Timothy Devere Cook .
Athenex Inc (ATNXQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Athenex Inc (ATNXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Athenex Inc (ATNXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Athenex Inc (ATNXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Athenex Inc Insider Transactions
- Download to Excel(.xls)
What does Albireo Pharma Inc do?
Who are the key executives at Albireo Pharma Inc?
Joseph Edelman is the 10 percent owner of Albireo Pharma Inc. Other key executives at Albireo Pharma Inc include director & President and CEO Cooper Ronald Harold Wilfred , Chief Human Resources Officer Michelle Graham , and CFO and Treasurer Harford Simon N.r. .
Albireo Pharma Inc (ALBO) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in Albireo Pharma Inc (ALBO). Other recent insider transactions involving Albireo Pharma Inc (ALBO) include a net sale of 2,814 shares made by Pamela Stephenson , a net sale of 3,285 shares made by Jan Mattsson , and a net sale of 1,878 shares made by Harford Simon N.r. .
In summary, during the past 3 months, insiders sold 0 shares of Albireo Pharma Inc (ALBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,134 shares of Albireo Pharma Inc (ALBO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 13,134 shares.
Albireo Pharma Inc (ALBO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Albireo Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does ARYA Sciences Acquisition Corp III do?
Who are the key executives at ARYA Sciences Acquisition Corp III?
Joseph Edelman is the director of ARYA Sciences Acquisition Corp III. Other key executives at ARYA Sciences Acquisition Corp III include director & 10 percent owner & Chief Executive Officer Adam Leo Stone , director & 10 percent owner & Chief Financial Officer Michael Seth Altman , and 10 percent owner Arya Sciences Holdings Iii .
ARYA Sciences Acquisition Corp III (ARYA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of ARYA Sciences Acquisition Corp III (ARYA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYA Sciences Acquisition Corp III (ARYA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ARYA Sciences Acquisition Corp III (ARYA)'s detailed insider trading history can be found in Insider Trading Tracker table.
ARYA Sciences Acquisition Corp III Insider Transactions
- Download to Excel(.xls)
What does Aldeyra Therapeutics Inc do?
Who are the key executives at Aldeyra Therapeutics Inc?
Joseph Edelman is the 10 percent owner of Aldeyra Therapeutics Inc. Other key executives at Aldeyra Therapeutics Inc include 10 percent owner Perceptive Life Sciences Master Fund Ltd , Chief Development Officer Stephen Machatha , and director & President and CEO Todd C Brady .
Aldeyra Therapeutics Inc (ALDX) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in Aldeyra Therapeutics Inc (ALDX). Other recent insider transactions involving Aldeyra Therapeutics Inc (ALDX) include a net sale of 2,074,234 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 41,305 shares made by Stephen Machatha , and a net sale of 26,402 shares made by Bruce Greenberg .
In summary, during the past 3 months, insiders sold 250,945 shares of Aldeyra Therapeutics Inc (ALDX) in total and bought 682,265 shares, with a net purchase of 431,320 shares. During the past 18 months, 3,007,444 shares of Aldeyra Therapeutics Inc (ALDX) were sold and 682,265 shares were bought by its insiders, resulting in a net sale of 2,325,179 shares.
Aldeyra Therapeutics Inc (ALDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aldeyra Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Leap Therapeutics Inc do?
Who are the key executives at Leap Therapeutics Inc?
Joseph Edelman is the 10 percent owner of Leap Therapeutics Inc. Other key executives at Leap Therapeutics Inc include Chief Scientific Officer Jason Baum , 10 percent owner Beigene, Ltd. , and VP & Head of Reg Affairs/Qual Christine Granfield .
Leap Therapeutics Inc (LPTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Leap Therapeutics Inc (LPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Leap Therapeutics Inc (LPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Leap Therapeutics Inc (LPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Leap Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Solid Biosciences Inc do?
Who are the key executives at Solid Biosciences Inc?
Joseph Edelman is the 10 percent owner of Solid Biosciences Inc. Other key executives at Solid Biosciences Inc include director & Chief Executive Officer Ilan Ganot , director & 10 percent owner Ra Capital Healthcare Fund Lp , and director & 10 percent owner Perceptive Life Sciences Master Fund Ltd .
Solid Biosciences Inc (SLDB) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in Solid Biosciences Inc (SLDB). Other recent insider transactions involving Solid Biosciences Inc (SLDB) include a net sale of 3,753 shares made by Ilan Ganot , a net purchase of 3,410,713 shares made by Perceptive Life Sciences Master Fund Ltd , and a net purchase of 904,160 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 462 shares of Solid Biosciences Inc (SLDB) in total and bought 0 shares, with a net sale of 462 shares. During the past 18 months, 26,233 shares of Solid Biosciences Inc (SLDB) were sold and 4,314,873 shares were bought by its insiders, resulting in a net purchase of 4,288,640 shares.
Solid Biosciences Inc (SLDB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Solid Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does VYNE Therapeutics Inc do?
Who are the key executives at VYNE Therapeutics Inc?
Joseph Edelman is the director & 10 percent owner of VYNE Therapeutics Inc. Other key executives at VYNE Therapeutics Inc include Chief Legal Officer and GC Mutya Harsch , 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Interim CFO Tyler Zeronda .
VYNE Therapeutics Inc (VYNE) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in VYNE Therapeutics Inc (VYNE). Other recent insider transactions involving VYNE Therapeutics Inc (VYNE) include a net purchase of 33,000 shares made by Patrick G Lepore , and a net purchase of 10,000 shares made by Mutya Harsch .
In summary, during the past 3 months, insiders sold 0 shares of VYNE Therapeutics Inc (VYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VYNE Therapeutics Inc (VYNE) were sold and 43,000 shares were bought by its insiders, resulting in a net purchase of 43,000 shares.
VYNE Therapeutics Inc (VYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.
VYNE Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does MeiraGTx Holdings PLC do?
Who are the key executives at MeiraGTx Holdings PLC?
Joseph Edelman is the 10 percent owner of MeiraGTx Holdings PLC. Other key executives at MeiraGTx Holdings PLC include director & 10 percent owner Perceptive Life Sciences Master Fund Ltd , 10 percent owner Johnson & Johnson , and 10 percent owner Johnson & Johnson Innovation - Jjdc, Inc. .
MeiraGTx Holdings PLC (MGTX) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in MeiraGTx Holdings PLC (MGTX). Other recent insider transactions involving MeiraGTx Holdings PLC (MGTX) include a net purchase of 4,347,826 shares made by Perceptive Life Sciences Master Fund Ltd ,
In summary, during the past 3 months, insiders sold 0 shares of MeiraGTx Holdings PLC (MGTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MeiraGTx Holdings PLC (MGTX) were sold and 4,347,826 shares were bought by its insiders, resulting in a net purchase of 4,347,826 shares.
MeiraGTx Holdings PLC (MGTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
MeiraGTx Holdings PLC Insider Transactions
- Download to Excel(.xls)
What does Lyra Therapeutics Inc do?
Who are the key executives at Lyra Therapeutics Inc?
Joseph Edelman is the director & 10 percent owner of Lyra Therapeutics Inc. Other key executives at Lyra Therapeutics Inc include director & Executive Chair Harlan Waksal , 10 percent owner Nbvm Gp, Llc , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .
Lyra Therapeutics Inc (LYRA) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in Lyra Therapeutics Inc (LYRA). Other recent insider transactions involving Lyra Therapeutics Inc (LYRA) include a net purchase of 3,610,832 shares made by Perceptive Life Sciences Master Fund Ltd , a net purchase of 1,805,416 shares made by Edward T Anderson , and a net purchase of 1,805,416 shares made by Nbvm Gp, Llc .
In summary, during the past 3 months, insiders sold 0 shares of Lyra Therapeutics Inc (LYRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lyra Therapeutics Inc (LYRA) were sold and 7,246,664 shares were bought by its insiders, resulting in a net purchase of 7,246,664 shares.
Lyra Therapeutics Inc (LYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lyra Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does VBI Vaccines Inc do?
Who are the key executives at VBI Vaccines Inc?
Joseph Edelman is the 10 percent owner of VBI Vaccines Inc. Other key executives at VBI Vaccines Inc include 10 percent owner Perceptive Life Sciences Master Fund Ltd , Chief Commercial Officer John Robert Dillman , and Director & Corp Development/IR Nell Beattie .
VBI Vaccines Inc (VBIV) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in VBI Vaccines Inc (VBIV). Other recent insider transactions involving VBI Vaccines Inc (VBIV) include a net sale of 10,894,749 shares made by Perceptive Life Sciences Master Fund Ltd , and a net purchase of 609,090 shares made by Steven Gillis .
In summary, during the past 3 months, insiders sold 0 shares of VBI Vaccines Inc (VBIV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 363,158 shares of VBI Vaccines Inc (VBIV) were sold and 609,090 shares were bought by its insiders, resulting in a net purchase of 245,932 shares.
VBI Vaccines Inc (VBIV)'s detailed insider trading history can be found in Insider Trading Tracker table.
VBI Vaccines Inc Insider Transactions
- Download to Excel(.xls)
What does Crinetics Pharmaceuticals Inc do?
Who are the key executives at Crinetics Pharmaceuticals Inc?
Joseph Edelman is the 10 percent owner of Crinetics Pharmaceuticals Inc. Other key executives at Crinetics Pharmaceuticals Inc include director & See Remarks Richard Scott Struthers , Chief Development Officer Dana Pizzuti , and Chief Operating Officer Jeff E. Knight .
Crinetics Pharmaceuticals Inc (CRNX) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in Crinetics Pharmaceuticals Inc (CRNX). Other recent insider transactions involving Crinetics Pharmaceuticals Inc (CRNX) include a net sale of 38,966 shares made by Stephen F. Betz , a net sale of 448,399 shares made by Richard Scott Struthers , and a net sale of 61,634 shares made by Dana Pizzuti .
In summary, during the past 3 months, insiders sold 294,664 shares of Crinetics Pharmaceuticals Inc (CRNX) in total and bought 0 shares, with a net sale of 294,664 shares. During the past 18 months, 723,722 shares of Crinetics Pharmaceuticals Inc (CRNX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 718,722 shares.
Crinetics Pharmaceuticals Inc (CRNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Crinetics Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does ADMA Biologics Inc do?
Who are the key executives at ADMA Biologics Inc?
Joseph Edelman is the 10 percent owner of ADMA Biologics Inc. Other key executives at ADMA Biologics Inc include director & President and CEO Adam S Grossman , EVP & CFO Brian Lenz , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .
ADMA Biologics Inc (ADMA) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in ADMA Biologics Inc (ADMA). Other recent insider transactions involving ADMA Biologics Inc (ADMA) include a net sale of 730,507 shares made by Adam S Grossman , a net sale of 1,500,000 shares made by Steve Elms , and a net sale of 382,769 shares made by Brian Lenz .
In summary, during the past 3 months, insiders sold 1,500,000 shares of ADMA Biologics Inc (ADMA) in total and bought 0 shares, with a net sale of 1,500,000 shares. During the past 18 months, 4,083,538 shares of ADMA Biologics Inc (ADMA) were sold and 191,958 shares were bought by its insiders, resulting in a net sale of 3,891,580 shares.
ADMA Biologics Inc (ADMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
ADMA Biologics Inc Insider Transactions
- Download to Excel(.xls)
What does Agile Therapeutics Inc do?
Who are the key executives at Agile Therapeutics Inc?
Joseph Edelman is the 10 percent owner of Agile Therapeutics Inc. Other key executives at Agile Therapeutics Inc include Chief Financial Officer Scott M Coiante , Chief Commercial Officer Amy Welsh , and director & Chief Executive Officer Alfred Altomari .
Agile Therapeutics Inc (AGRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Agile Therapeutics Inc (AGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Agile Therapeutics Inc (AGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Agile Therapeutics Inc (AGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Agile Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Kadmon Holdings Inc do?
Who are the key executives at Kadmon Holdings Inc?
Joseph Edelman is the 10 percent owner of Kadmon Holdings Inc. Other key executives at Kadmon Holdings Inc include director & President & CEO Harlan Waksal , Executive Vice President & CMO John L Ryan , and EVP & Chief Financial Officer Steven Meehan .
Kadmon Holdings Inc (KDMN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Kadmon Holdings Inc (KDMN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kadmon Holdings Inc (KDMN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Kadmon Holdings Inc (KDMN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kadmon Holdings Inc Insider Transactions
- Download to Excel(.xls)
What does Dova Pharmaceuticals Inc do?
Who are the key executives at Dova Pharmaceuticals Inc?
Joseph Edelman is the 10 percent owner of Dova Pharmaceuticals Inc. Other key executives at Dova Pharmaceuticals Inc include 10 percent owner Perceptive Advisors Llc , 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Chief Medical Officer Allen Lee F Md Phd .
Dova Pharmaceuticals Inc (DOVA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Dova Pharmaceuticals Inc (DOVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dova Pharmaceuticals Inc (DOVA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Dova Pharmaceuticals Inc (DOVA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dova Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Foamix Pharmaceuticals Ltd do?
Who are the key executives at Foamix Pharmaceuticals Ltd?
Joseph Edelman is the 10 percent owner of Foamix Pharmaceuticals Ltd. Other key executives at Foamix Pharmaceuticals Ltd include Chief Scientific Officer Iain Stuart , director & CEO David Domzalski , and CLO and General Counsel Mutya Harsch .
Foamix Pharmaceuticals Ltd (FOMX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Foamix Pharmaceuticals Ltd (FOMX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Foamix Pharmaceuticals Ltd (FOMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Foamix Pharmaceuticals Ltd (FOMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Foamix Pharmaceuticals Ltd Insider Transactions
- Download to Excel(.xls)
What does Motus GI Holdings Inc do?
Who are the key executives at Motus GI Holdings Inc?
Joseph Edelman is the 10 percent owner of Motus GI Holdings Inc. Other key executives at Motus GI Holdings Inc include 10 percent owner Orchestra Biomed Holdings, Inc. , Chief Financial Officer Ravit Ram , and Chief Accounting Officer Elad Amor .
Motus GI Holdings Inc (MOTS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Motus GI Holdings Inc (MOTS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Motus GI Holdings Inc (MOTS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Motus GI Holdings Inc (MOTS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Motus GI Holdings Inc Insider Transactions
- Download to Excel(.xls)
What does Amicus Therapeutics Inc do?
Who are the key executives at Amicus Therapeutics Inc?
Joseph Edelman is the 10 percent owner of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .
Amicus Therapeutics Inc (FOLD) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 634,200 shares made by John F Crowley , a net sale of 260,446 shares made by Bradley L Campbell , and a net sale of 51,919 shares made by David Michael Clark .
In summary, during the past 3 months, insiders sold 115,222 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 115,222 shares. During the past 18 months, 1,232,982 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,232,982 shares.
Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amicus Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does La Jolla Pharmaceutical Co do?
Who are the key executives at La Jolla Pharmaceutical Co?
Joseph Edelman is the 10 percent owner of La Jolla Pharmaceutical Co. Other key executives at La Jolla Pharmaceutical Co include director & 10 percent owner Kevin C Tang , Chief Financial Officer Michael S Hearne , and director & Chief Executive Officer Larry G. Edwards .
La Jolla Pharmaceutical Co (LJPC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of La Jolla Pharmaceutical Co (LJPC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of La Jolla Pharmaceutical Co (LJPC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
La Jolla Pharmaceutical Co (LJPC)'s detailed insider trading history can be found in Insider Trading Tracker table.
La Jolla Pharmaceutical Co Insider Transactions
- Download to Excel(.xls)
What does Corium International Inc do?
Who are the key executives at Corium International Inc?
Joseph Edelman is the 10 percent owner of Corium International Inc. Other key executives at Corium International Inc include 10 percent owner Broadfin Healthcare Master Fund Ltd , 10 percent owner Broadfin Capital, Llc , and 10 percent owner Kevin Kotler .
Corium International Inc (CORI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Corium International Inc (CORI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Corium International Inc (CORI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Corium International Inc (CORI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Corium International Inc Insider Transactions
- Download to Excel(.xls)
What does ARYA Sciences Acquisition Corp do?
Who are the key executives at ARYA Sciences Acquisition Corp?
Joseph Edelman is the director of ARYA Sciences Acquisition Corp. Other key executives at ARYA Sciences Acquisition Corp include director & Chief Executive Officer Adam Leo Stone , and director & Chief Financial Officer Michael Seth Altman .
ARYA Sciences Acquisition Corp (ARYAU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of ARYA Sciences Acquisition Corp (ARYAU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYA Sciences Acquisition Corp (ARYAU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ARYA Sciences Acquisition Corp (ARYAU)'s detailed insider trading history can be found in Insider Trading Tracker table.
ARYA Sciences Acquisition Corp Insider Transactions
- Download to Excel(.xls)
What does Zogenix Inc do?
Who are the key executives at Zogenix Inc?
Joseph Edelman is the 10 percent owner of Zogenix Inc. Other key executives at Zogenix Inc include EVP & CHIEF COMMERCIAL OFFICER Ashish M Sagrolikar , EVP/Chief Development Officer Gail M Farfel , and director & President and CEO Stephen J Farr .
Zogenix Inc (ZGNX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Zogenix Inc (ZGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zogenix Inc (ZGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Zogenix Inc (ZGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zogenix Inc Insider Transactions
- Download to Excel(.xls)
What does Verrica Pharmaceuticals Inc do?
Who are the key executives at Verrica Pharmaceuticals Inc?
Joseph Edelman is the 10 percent owner of Verrica Pharmaceuticals Inc. Other key executives at Verrica Pharmaceuticals Inc include 10 percent owner Perceptive Life Sciences Master Fund Ltd , director & President and CEO Ted White , and Chief Commercial Officer Joe Bonaccorso .
Verrica Pharmaceuticals Inc (VRCA) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in Verrica Pharmaceuticals Inc (VRCA). Other recent insider transactions involving Verrica Pharmaceuticals Inc (VRCA) include a net purchase of 2,060,199 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 84,376 shares made by Ted White , and a net sale of 71,108 shares made by Joe Bonaccorso .
In summary, during the past 3 months, insiders sold 0 shares of Verrica Pharmaceuticals Inc (VRCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 288,608 shares of Verrica Pharmaceuticals Inc (VRCA) were sold and 2,260,199 shares were bought by its insiders, resulting in a net purchase of 1,971,591 shares.
Verrica Pharmaceuticals Inc (VRCA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verrica Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Global Blood Therapeutics Inc do?
Who are the key executives at Global Blood Therapeutics Inc?
Joseph Edelman is the 10 percent owner of Global Blood Therapeutics Inc. Other key executives at Global Blood Therapeutics Inc include Chief Financial Officer Jeffrey S Farrow , See Remarks Nazila Habibizad , and Chief Human Resources Officer Carrie Krehlik .
Global Blood Therapeutics Inc (GBT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Global Blood Therapeutics Inc (GBT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Global Blood Therapeutics Inc (GBT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Global Blood Therapeutics Inc (GBT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Global Blood Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Aravive Inc do?
Who are the key executives at Aravive Inc?
Joseph Edelman is the 10 percent owner of Aravive Inc. Other key executives at Aravive Inc include Chief Commercial Officer Maria Carolina Petrini , Chief Medical Officer Robert B. Geller , and Chief Financial Officer Rudy Howard .
Aravive Inc (ARAV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aravive Inc (ARAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aravive Inc (ARAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aravive Inc (ARAV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aravive Inc Insider Transactions
- Download to Excel(.xls)
What does Talphera Inc do?
Who are the key executives at Talphera Inc?
Joseph Edelman is the 10 percent owner of Talphera Inc. Other key executives at Talphera Inc include director & Chief Executive Officer Vincent J. Angotti , director & Chief Medical Officer Pamela P Palmer , and Chief Engineering Officer Badri N Dasu .
Talphera Inc (TLPH) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in Talphera Inc (TLPH). Other recent insider transactions involving Talphera Inc (TLPH) include a net purchase of 20,000 shares made by Vincent J. Angotti , and a net sale of 16,956 shares made by Pamela P Palmer .
In summary, during the past 3 months, insiders sold 0 shares of Talphera Inc (TLPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 16,956 shares of Talphera Inc (TLPH) were sold and 20,000 shares were bought by its insiders, resulting in a net purchase of 3,044 shares.
Talphera Inc (TLPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Talphera Inc Insider Transactions
- Download to Excel(.xls)
What does Aegerion Pharmaceuticals Inc do?
Who are the key executives at Aegerion Pharmaceuticals Inc?
Joseph Edelman is the 10 percent owner of Aegerion Pharmaceuticals Inc. Other key executives at Aegerion Pharmaceuticals Inc include director & Chief Executive Officer Mary T Szela , other: See Remarks Gregory D Perry , and 10 percent owner Broadfin Healthcare Master Fund Ltd .
Aegerion Pharmaceuticals Inc (AEGR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aegerion Pharmaceuticals Inc (AEGR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aegerion Pharmaceuticals Inc (AEGR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aegerion Pharmaceuticals Inc (AEGR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aegerion Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does XTL Biopharmaceuticals Ltd do?
Who are the key executives at XTL Biopharmaceuticals Ltd?
Joseph Edelman is the 10 percent owner of XTL Biopharmaceuticals Ltd. Other key executives at XTL Biopharmaceuticals Ltd include 10 percent owner Perceptive Advisors Llc , 10 percent owner Perceptive Life Sciences Master Fund Ltd , and 10 percent owner Michael Cho .
XTL Biopharmaceuticals Ltd (XTLB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of XTL Biopharmaceuticals Ltd (XTLB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XTL Biopharmaceuticals Ltd (XTLB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
XTL Biopharmaceuticals Ltd (XTLB)'s detailed insider trading history can be found in Insider Trading Tracker table.
XTL Biopharmaceuticals Ltd Insider Transactions
- Download to Excel(.xls)
What does ANI Pharmaceuticals Inc do?
Who are the key executives at ANI Pharmaceuticals Inc?
Joseph Edelman is the 10 percent owner of ANI Pharmaceuticals Inc. Other key executives at ANI Pharmaceuticals Inc include SVP - CORP. DEV. & STRATEGY Chad Gassert , director & HEAD OF R&D & COO-NOVITIUM OPS Muthusamy Shanmugam , and SR. VP & GENERAL COUNSEL & SEC. Meredith Cook .
ANI Pharmaceuticals Inc (ANIP) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in ANI Pharmaceuticals Inc (ANIP). Other recent insider transactions involving ANI Pharmaceuticals Inc (ANIP) include a net sale of 626,190 shares made by Muthusamy Shanmugam , a net sale of 160,000 shares made by Chad Gassert , and a net sale of 1,500 shares made by Meredith Cook .
In summary, during the past 3 months, insiders sold 249,882 shares of ANI Pharmaceuticals Inc (ANIP) in total and bought 0 shares, with a net sale of 249,882 shares. During the past 18 months, 1,391,108 shares of ANI Pharmaceuticals Inc (ANIP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,391,108 shares.
ANI Pharmaceuticals Inc (ANIP)'s detailed insider trading history can be found in Insider Trading Tracker table.
ANI Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Antares Pharma Inc do?
Who are the key executives at Antares Pharma Inc?
Joseph Edelman is the 10 percent owner of Antares Pharma Inc. Other key executives at Antares Pharma Inc include See Remarks Peter C Richardson , Executive Vice President & CFO Fred M Powell , and See Remarks Peter J Graham .
Antares Pharma Inc (ATRS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Antares Pharma Inc (ATRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antares Pharma Inc (ATRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Antares Pharma Inc (ATRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Antares Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does Palatin Technologies Inc do?
Who are the key executives at Palatin Technologies Inc?
Joseph Edelman is the 10 percent owner of Palatin Technologies Inc. Other key executives at Palatin Technologies Inc include Executive Vice President & CFO Stephen T Wills , director & President and CEO Carl Spana , and director & Exec. VP Research and Devel. Perry B Molinoff .
Palatin Technologies Inc (PTN) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in Palatin Technologies Inc (PTN). Other recent insider transactions involving Palatin Technologies Inc (PTN) include a net sale of 5,700 shares made by Deveer Robert K Jr , a net purchase of 5,002 shares made by Stephen T Wills , and a net sale of 400 shares made by Alan W Dunton .
In summary, during the past 3 months, insiders sold 11,700 shares of Palatin Technologies Inc (PTN) in total and bought 6,000 shares, with a net sale of 5,700 shares. During the past 18 months, 17,098 shares of Palatin Technologies Inc (PTN) were sold and 26,000 shares were bought by its insiders, resulting in a net purchase of 8,902 shares.
Palatin Technologies Inc (PTN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Palatin Technologies Inc Insider Transactions
- Download to Excel(.xls)
What does SCYNEXIS Inc do?
Who are the key executives at SCYNEXIS Inc?
Joseph Edelman is the 10 percent owner of SCYNEXIS Inc. Other key executives at SCYNEXIS Inc include Chief Financial Officer Ivor Macleod , General Counsel Scott Sukenick , and Interim CFO Lawrence R Hoffman .
SCYNEXIS Inc (SCYX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of SCYNEXIS Inc (SCYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SCYNEXIS Inc (SCYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
SCYNEXIS Inc (SCYX)'s detailed insider trading history can be found in Insider Trading Tracker table.
SCYNEXIS Inc Insider Transactions
- Download to Excel(.xls)
What does Astria Therapeutics Inc do?
Who are the key executives at Astria Therapeutics Inc?
Joseph Edelman is the director & 10 percent owner of Astria Therapeutics Inc. Other key executives at Astria Therapeutics Inc include Chief Medical Officer Christopher Morabito , director & 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Chief Business Officer Andrea Matthews .
Astria Therapeutics Inc (ATXS) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in Astria Therapeutics Inc (ATXS). Other recent insider transactions involving Astria Therapeutics Inc (ATXS) include a net purchase of 5,204,223 shares made by Perceptive Life Sciences Master Fund Ltd , and a net sale of 20,000 shares made by Christopher Morabito .
In summary, during the past 3 months, insiders sold 10,000 shares of Astria Therapeutics Inc (ATXS) in total and bought 0 shares, with a net sale of 10,000 shares. During the past 18 months, 20,000 shares of Astria Therapeutics Inc (ATXS) were sold and 5,204,223 shares were bought by its insiders, resulting in a net purchase of 5,184,223 shares.
Astria Therapeutics Inc (ATXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Astria Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does IsoPlexis Corp do?
Who are the key executives at IsoPlexis Corp?
Joseph Edelman is the 10 percent owner of IsoPlexis Corp. Other key executives at IsoPlexis Corp include Chief Financial Officer John Strahley , SVP & GC & Secretary Rew Richard W. Ii , and director & Chief Executive Officer Sean Mackay .
IsoPlexis Corp (ISO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of IsoPlexis Corp (ISO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of IsoPlexis Corp (ISO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
IsoPlexis Corp (ISO)'s detailed insider trading history can be found in Insider Trading Tracker table.
IsoPlexis Corp Insider Transactions
- Download to Excel(.xls)
What does Prometheus Biosciences Inc do?
Who are the key executives at Prometheus Biosciences Inc?
Joseph Edelman is the 10 percent owner of Prometheus Biosciences Inc. Other key executives at Prometheus Biosciences Inc include Chief Financial Officer Keith W Marshall , director & President and CEO Mark C. Mckenna , and 10 percent owner Cedars Sinai Intellectual Property Co .
Prometheus Biosciences Inc (RXDX) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in Prometheus Biosciences Inc (RXDX). Other recent insider transactions involving Prometheus Biosciences Inc (RXDX) include a net sale of 125,000 shares made by Mark C. Mckenna , a net sale of 30,000 shares made by Keith W Marshall , and a net sale of 865,000 shares made by Cedars Sinai Intellectual Property Co .
In summary, during the past 3 months, insiders sold 0 shares of Prometheus Biosciences Inc (RXDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,020,000 shares of Prometheus Biosciences Inc (RXDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,020,000 shares.
Prometheus Biosciences Inc (RXDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Prometheus Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Rain Oncology Inc do?
Who are the key executives at Rain Oncology Inc?
Joseph Edelman is the 10 percent owner of Rain Oncology Inc. Other key executives at Rain Oncology Inc include 10 percent owner Kevin C Tang , Principal Fin. & Acc. Officer Josephine Bruce , and 10 percent owner Tang Capital Management Llc .
Rain Oncology Inc (RAIN) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in Rain Oncology Inc (RAIN). Other recent insider transactions involving Rain Oncology Inc (RAIN) include a net purchase of 1,198,445 shares made by Kevin C Tang , a net sale of 995,000 shares made by Boxer Capital, Llc , and a net purchase of 122,000 shares made by Franklin M Berger .
In summary, during the past 3 months, insiders sold 0 shares of Rain Oncology Inc (RAIN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,168,973 shares of Rain Oncology Inc (RAIN) were sold and 1,494,418 shares were bought by its insiders, resulting in a net purchase of 325,445 shares.
Rain Oncology Inc (RAIN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rain Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does Landos Biopharma Inc do?
Who are the key executives at Landos Biopharma Inc?
Joseph Edelman is the director of Landos Biopharma Inc. Other key executives at Landos Biopharma Inc include 10 percent owner Perceptive Xontogeny Venture Fund Ii, Lp , 10 percent owner Roderick Wong , and 10 percent owner Rtw Investments, Lp .
Landos Biopharma Inc (LABP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Landos Biopharma Inc (LABP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Landos Biopharma Inc (LABP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Landos Biopharma Inc (LABP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Landos Biopharma Inc Insider Transactions
- Download to Excel(.xls)
What does Cerevel Therapeutics Holdings Inc do?
Who are the key executives at Cerevel Therapeutics Holdings Inc?
Joseph Edelman is the director of Cerevel Therapeutics Holdings Inc. Other key executives at Cerevel Therapeutics Holdings Inc include director & See Remarks N Anthony Coles , Chief Scientific Officer John Renger , and Chief Medical Officer Ramiro Sanchez .
Cerevel Therapeutics Holdings Inc (CERE) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in Cerevel Therapeutics Holdings Inc (CERE). Other recent insider transactions involving Cerevel Therapeutics Holdings Inc (CERE) include a net sale of 802,506 shares made by N Anthony Coles , a net sale of 37,652 shares made by Ramiro Sanchez , and a net sale of 24,572 shares made by Scott Akamine .
In summary, during the past 3 months, insiders sold 150,000 shares of Cerevel Therapeutics Holdings Inc (CERE) in total and bought 0 shares, with a net sale of 150,000 shares. During the past 18 months, 1,141,157 shares of Cerevel Therapeutics Holdings Inc (CERE) were sold and 17,422,701 shares were bought by its insiders, resulting in a net purchase of 16,281,544 shares.
Cerevel Therapeutics Holdings Inc (CERE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cerevel Therapeutics Holdings Inc Insider Transactions
- Download to Excel(.xls)
What does Nautilus Biotechnology Inc do?
Who are the key executives at Nautilus Biotechnology Inc?
Joseph Edelman is the 10 percent owner of Nautilus Biotechnology Inc. Other key executives at Nautilus Biotechnology Inc include director & 10 percent owner & CEO & President & and Secretary Sujal M Patel , Senior VP & Product Development Subramanian Sankar , and Chief People Officer Gwen E Weld .
Nautilus Biotechnology Inc (NAUT) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in Nautilus Biotechnology Inc (NAUT). Other recent insider transactions involving Nautilus Biotechnology Inc (NAUT) include a net purchase of 50,000 shares made by Sujal M Patel ,
In summary, during the past 3 months, insiders sold 0 shares of Nautilus Biotechnology Inc (NAUT) in total and bought 50,000 shares, with a net purchase of 50,000 shares. During the past 18 months, 0 shares of Nautilus Biotechnology Inc (NAUT) were sold and 50,000 shares were bought by its insiders, resulting in a net purchase of 50,000 shares.
Nautilus Biotechnology Inc (NAUT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nautilus Biotechnology Inc Insider Transactions
- Download to Excel(.xls)
What does LianBio do?
Who are the key executives at LianBio?
Joseph Edelman is the 10 percent owner of LianBio. Other key executives at LianBio include 10 percent owner Perceptive Life Sciences Master Fund Ltd , director & 10 percent owner Perceptive Advisors Llc , and Chief Financial Officer Yi Larson .
LianBio (LIANY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of LianBio (LIANY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of LianBio (LIANY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
LianBio (LIANY)'s detailed insider trading history can be found in Insider Trading Tracker table.
LianBio Insider Transactions
- Download to Excel(.xls)
What does ARYA Sciences Acquisition Corp IV do?
Who are the key executives at ARYA Sciences Acquisition Corp IV?
Joseph Edelman is the director of ARYA Sciences Acquisition Corp IV. Other key executives at ARYA Sciences Acquisition Corp IV include Chief Business Officer Konstantin Poukalov , director & 10 percent owner & Chief Executive Officer Adam Leo Stone , and director & 10 percent owner & Chief Financial Officer Michael Seth Altman .
ARYA Sciences Acquisition Corp IV (ARYD) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of ARYA Sciences Acquisition Corp IV (ARYD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYA Sciences Acquisition Corp IV (ARYD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ARYA Sciences Acquisition Corp IV (ARYD)'s detailed insider trading history can be found in Insider Trading Tracker table.
ARYA Sciences Acquisition Corp IV Insider Transactions
- Download to Excel(.xls)
What does ARYA Sciences Acquisition Corp V do?
Who are the key executives at ARYA Sciences Acquisition Corp V?
Joseph Edelman is the director of ARYA Sciences Acquisition Corp V. Other key executives at ARYA Sciences Acquisition Corp V include Chief Business Officer Konstantin Poukalov , director & 10 percent owner & Chief Executive Officer Adam Leo Stone , and director & 10 percent owner & Chief Financial Officer Michael Seth Altman .
ARYA Sciences Acquisition Corp V (ARYE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of ARYA Sciences Acquisition Corp V (ARYE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYA Sciences Acquisition Corp V (ARYE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ARYA Sciences Acquisition Corp V (ARYE)'s detailed insider trading history can be found in Insider Trading Tracker table.
ARYA Sciences Acquisition Corp V Insider Transactions
- Download to Excel(.xls)
What does Acrivon Therapeutics Inc do?
Who are the key executives at Acrivon Therapeutics Inc?
Joseph Edelman is the 10 percent owner of Acrivon Therapeutics Inc. Other key executives at Acrivon Therapeutics Inc include 10 percent owner Perceptive Life Sciences Master Fund Ltd , Chief Legal Officer Mary Miller , and director & President and CEO Peter Blume-jensen .
Acrivon Therapeutics Inc (ACRV) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in Acrivon Therapeutics Inc (ACRV). Other recent insider transactions involving Acrivon Therapeutics Inc (ACRV) include a net purchase of 392,035 shares made by Chione Ltd , a net purchase of 3,389,500 shares made by Ra Capital Healthcare Fund Lp , and a net purchase of 2,353,000 shares made by Perceptive Life Sciences Master Fund Ltd .
In summary, during the past 3 months, insiders sold 0 shares of Acrivon Therapeutics Inc (ACRV) in total and bought 2,353,000 shares, with a net purchase of 2,353,000 shares. During the past 18 months, 7,965 shares of Acrivon Therapeutics Inc (ACRV) were sold and 6,142,500 shares were bought by its insiders, resulting in a net purchase of 6,134,535 shares.
Acrivon Therapeutics Inc (ACRV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acrivon Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Chembio Diagnostics Inc do?
Who are the key executives at Chembio Diagnostics Inc?
Joseph Edelman is the 10 percent owner of Chembio Diagnostics Inc. Other key executives at Chembio Diagnostics Inc include 10 percent owner Perceptive Credit Advisors, Llc , 10 percent owner Perceptive Advisors Llc , and See remarks Paul Angelico .
Chembio Diagnostics Inc (CEMI) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in Chembio Diagnostics Inc (CEMI). Other recent insider transactions involving Chembio Diagnostics Inc (CEMI) include a net purchase of 1,490,120 shares made by Perceptive Credit Advisors, Llc ,
In summary, during the past 3 months, insiders sold 0 shares of Chembio Diagnostics Inc (CEMI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Chembio Diagnostics Inc (CEMI) were sold and 1,490,120 shares were bought by its insiders, resulting in a net purchase of 1,490,120 shares.
Chembio Diagnostics Inc (CEMI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Chembio Diagnostics Inc Insider Transactions
- Download to Excel(.xls)
What does Soleno Therapeutics Inc do?
Who are the key executives at Soleno Therapeutics Inc?
Joseph Edelman is the 10 percent owner of Soleno Therapeutics Inc. Other key executives at Soleno Therapeutics Inc include 10 percent owner Vivo Opportunity Fund Holdings, L.p. , See Remarks Patricia C Hirano , and See Remarks Kristen Yen .
Soleno Therapeutics Inc (SLNO) Insider Trades Summary
Over the past 18 months, Joseph Edelman made no insider transaction in Soleno Therapeutics Inc (SLNO). Other recent insider transactions involving Soleno Therapeutics Inc (SLNO) include a net purchase of 1,210,087 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 196,136 shares made by Bhatnagar Anish , and a net sale of 52,057 shares made by Kristen Yen .
In summary, during the past 3 months, insiders sold 1,129,833 shares of Soleno Therapeutics Inc (SLNO) in total and bought 0 shares, with a net sale of 1,129,833 shares. During the past 18 months, 1,849,928 shares of Soleno Therapeutics Inc (SLNO) were sold and 1,210,087 shares were bought by its insiders, resulting in a net sale of 639,841 shares.
Soleno Therapeutics Inc (SLNO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Soleno Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
Joseph Edelman Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph Edelman. You might contact Joseph Edelman via mailing address: C/o Perceptive Advisors Llc, 51 Astor Place, 10th Floor, New York Ny 10003.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
